Retatrutide 2381089-83-2

Skelbimo nr. 295966, įdėtas 2025-03-24 · Perskaitė:

Retatrutide (RETA; LY3437943) is a novel triple agonist of the GIP, GLP-1 and glucagon receptors under investigation for obesity treatment.

Kontaktai

Vardas: Alice

El. paštas: